The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis
Status:
Terminated
Trial end date:
2014-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and tolerability of cyclically-dosed rectal
budesonide foam in participants with active ulcerative proctitis (UP) or ulcerative
proctosigmoiditis (UPS).
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.